Medpace Holdings, Inc. President and CEO August J. Troendle filed a Form 4 on September 23, 2026, disclosing the sale of 70,901 shares of common stock across two trading days.
Barton John Bedard, Chief Financial Officer of Moving iMage Technologies Inc., filed a Form 4 with the SEC on September 23, 2026, disclosing the grant of employee stock options on April 27, 2026.
John T. Hall, Chief Executive Officer and Director of Intapp, Inc. (NASDAQ:INTA), filed a Form 4 on September 23, 2026, disclosing the exercise of stock options and the same-day sale of 3,000 shares of common stock on September 21, 2026.
Bruno Guicardi Neto, President of North American and European Operations at CI&T Inc (NYSE:CINT) and a 10% owner, filed a Form 4 on September 23, 2026, disclosing open-market purchases of Class A Common Stock across three consecutive trading days.
Jeffrey W. Baumgartner, Executive Vice President of R&D at Cirrus Logic, Inc., filed a Form 4 on September 23, 2026, reporting a sale of common stock that occurred on September 21, 2026.
James Pursley, President of Hinge Health, Inc. (NYSE:HNGE), filed a Form 4 on September 23, 2026, disclosing the sale of 33,000 shares of Class A Common Stock on September 21, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
A Form 4 filed on September 23, 2026 by Kamada Ltd director Assaf Itshayek discloses adjustments to the exercise prices of two previously reported employee stock option grants, effective August 27, 2026, following a special cash dividend declared by the company's board.
Eran Nir, VP of Operations at Kamada Ltd, filed a Form 4 on September 23, 2026, disclosing adjustments to two previously reported employee stock option grants following a special cash dividend declared by the company's board of directors.
Chaime Orlev, Chief Financial Officer of Kamada Ltd, filed a Form 4 on September 23, 2026, disclosing adjustments to three previously reported employee stock option grants following the company's special cash dividend distribution declared on August 17, 2026.
Director Leon Recanati filed a Form 4 with the SEC on September 23, 2026, disclosing adjustments to three previously reported employee stock options held in connection with Kamada Ltd (NASDAQ:KMDA) following a special cash dividend distribution.